Close Menu

The Earlier You Know

Much of the "War on Cancer" money goes to curing the disease but in the latest issue of Wired, Thomas Goetz writes about the Canary Foundation, which is focused on early detection.  There, researchers are working on developing biomarker blood tests -- using proteomics to pinpoint proteins -- and new imaging tools. "A good biomarker will tell us something we don't know.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.